Evaluation of anti-Yersinia psueudotuberculosis-derived mitogen antibody in intravenous immunoglobulin products.
ELISA
Intravenous immunoglobulin
Serological testing
Superantigen
Yersinia pseudotuberculosis
Journal
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
06
04
2022
revised:
20
07
2022
accepted:
27
07
2022
pubmed:
8
8
2022
medline:
14
9
2022
entrez:
7
8
2022
Statut:
ppublish
Résumé
Antibody titers against the superantigen, Yersinia pseudotuberculosis-derived mitogen, suggestive of mediating Kawasaki disease-like manifestation in Y. pseudotuberculosis infections, in immunoglobulin products were evaluated. Trace, but detectable titer was demonstrated in the products. Thus, attention is required when evaluating anti-Y. pseudotuberculosis-derived mitogen IgG titers in patient sera post intravenous immunoglobulin therapy.
Identifiants
pubmed: 35934232
pii: S1341-321X(22)00216-1
doi: 10.1016/j.jiac.2022.07.020
pii:
doi:
Substances chimiques
Immunoglobulins, Intravenous
0
Mitogens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1582-1583Informations de copyright
Copyright © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest IM received lecture fee from Nihon Pharmaceutical Co., Ltd.